Low-dose IL-2 for patients with systemic lupus erythematosus

被引：1
|
作者：
He, Jing [1 ]
Sun, Xiaolin [1 ]
Li, Zhanguo [1 ]
机构：
[1] Peking Univ, Peoples Hosp, Dept Rheumatol & Immunol, Beijing 100044, Peoples R China
来源：
LANCET RHEUMATOLOGY | 2019年 / 1卷 / 04期
关键词：
SAFETY;
D O I：
10.1016/S2665-9913(19)30107-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E203 / E203
页数：1
相关论文
共 50 条
  • [41] LOW-DOSE GLUCOCORTICOIDS WITHDRAWN IN SYSTEMIC LUPUS ERYTHEMATOSUS: A DESIRABLE AND ATTAINABLE GOAL
    Ji, L.
    Gao, D.
    Hao, Y.
    Zhang, Z.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 642 - 643
  • [42] Low-dose epoprostenol improved pulmonary hypertension in a patient with systemic lupus erythematosus
    Yoshihiro Matsukawa
    Kohmei Igei
    Takamasa Nozaki
    Takafumi Ohki
    Takako Shimizu
    Noboru Kitamura
    Ko Mitamura
    Masami Takei
    Yuji Kasamaki
    Shigemasa Sawada
    Clinical Rheumatology, 2007, 26 : 582 - 583
  • [43] Low-dose epoprostenol improved pulmonary hypertension in a patient with systemic lupus erythematosus
    Matsukawa, Yoshihiro
    Igei, Kohmei
    Nozaki, Takamasa
    Ohki, Takafumi
    Shimizu, Takako
    Kitamura, Noboru
    Mitamura, Ko
    Takei, Masami
    Kasamaki, Yuji
    Sawada, Shigemasa
    CLINICAL RHEUMATOLOGY, 2007, 26 (04) : 582 - 583
  • [44] Altered regulation of IL-2 production in systemic lupus erythematosus: an evolving paradigm
    Kammer, GM
    JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (04): : 836 - 840
  • [45] IL-2 DEPRIVATION OF FOXP3+TREG IN SYSTEMIC LUPUS ERYTHEMATOSUS
    von Spee, C.
    Wassermann, N.
    Humrich, J. Y.
    Riemekasten, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 526 - 526
  • [46] CHARACTERIZATION OF LYMPHOCYTES THAT SUPPRESS IL-2 PRODUCTION IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    LINKERISRAELI, M
    GRAY, JD
    QUISMORIO, FP
    HORWITZ, DA
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1988, 73 (02): : 236 - 241
  • [47] ASSOCIATION BETWEEN IL-2 AND IFNFR GENE POLYMORPHISMS AND SYSTEMIC LUPUS ERYTHEMATOSUS
    Yang, Ying
    Liang, Hanyue
    Yang, Ying
    Chen, Lin
    Chen, Shuiying
    Liu, Huihuang
    Chen, Xiaohong
    ACTA MEDICA MEDITERRANEA, 2019, 35 (03): : 1487 - 1491
  • [48] EFFICACY AND SAFETY OF LOW-DOSE IL-2 IN PATIENTS WITH MULTIPLE MYOSITIS/DERMATOMYOSITIS
    Sun, He-Hua
    Zhang, Sheng-xiao
    Wang, Jia
    Hao, Yu-Fei
    Liu, Guang-Ying
    Wang, Caihong
    Gao, Chong
    Li Xiao-Feng
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 201 - 201
  • [49] Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus
    von Spee-Mayer, Caroline
    Siegert, Elise
    Abdirama, Dimas
    Rose, Angelika
    Klaus, Anika
    Alexander, Tobias
    Enghard, Philipp
    Sawitzki, Birgit
    Hiepe, Falk
    Radbruch, Andreas
    Burmester, Gerd-Ruediger
    Riemekasten, Gabriela
    Humrich, Jens Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (07) : 1407 - 1415
  • [50] Should low-dose aspirin also be a background therapy for all patients with systemic lupus erythematosus (SLE)?
    Malaviya, AN
    Mourou, M
    LUPUS, 2000, 9 (07) : 561 - 562
12345